)
Visual
earnings real time
Anebulo Pharmaceuticals (ANEB) investor relations material
Anebulo Pharmaceuticals Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary13 Nov, 2025
Executive summary
Focused on developing selonabant, a cannabinoid receptor antagonist, for cannabis-induced toxicity, prioritizing pediatric IV formulation due to unmet medical need and regulatory feedback.
Initiated Phase 1 single ascending dose (SAD) study of IV selonabant for acute cannabis-induced toxicity in children, with FDA clearance and NIDA grant support; ongoing observational study in emergency departments.
No product revenue to date; operations funded by equity raises, grants, and a loan facility.
Board approved a proposed reverse stock split as part of a potential going private transaction; process impacted by government shutdown and SEC delays.
Financial highlights
Net loss for the quarter ended September 30, 2025 was $2.16 million, compared to $2.20 million for the same quarter last year; Q1 FY2026 net loss was $2.2 million on $2.3 million in expenses.
Operating expenses decreased to $2.26 million from $2.41 million year-over-year, driven by lower R&D costs.
Cash and cash equivalents were $10.4 million as of September 30, 2025, with access to an additional $3.0 million via a loan agreement.
No revenue recognized; grant income of $809,991 recognized in Q1 FY2026, down from $245,000 year-over-year.
Outlook and guidance
Cash and equivalents, plus available loan facility, expected to fund operations for at least 12 months from the report date.
Ongoing focus on developing selonabant IV for pediatric cannabis toxicity, with support from NIDA and collaboration with FDA.
Anticipates continued operating losses and need for additional capital to advance clinical programs; R&D expenses expected to increase as clinical studies progress.
Board expects to provide further updates on strategic alternatives and the reverse stock split by year-end.
What factors enable faster IV pediatric approval?
What specific hurdles remain for going private?
Explain the Q1 grant income decrease vs NIDA award.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Anebulo Pharmaceuticals earnings date
Q2 202613 Feb, 2026
Next Anebulo Pharmaceuticals earnings date
Q2 202613 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing treatments for acute cannabinoid intoxication (ACI) and substance abuse. Its primary product candidate, ANEB-001, is a cannabinoid receptor antagonist aimed at rapidly reversing the effects of cannabinoid overdose. The company is headquartered in Lakeway, Texas, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage